Comparison of the inferred amino acid sequence of outer-membrane protein PIB from gonococcal strain P9 with those from other serovars reveals that sequence variations occur in two discrete regions of the molecule centred on residues 1% (Varl) and 237 (Var2). A series of peptides spanning the amino acid sequence of the protein were synthesized on solid-phase supports and reacted with a panel of monoclonal antibodies (mAbs) which recognize either type-specific or conserved antigenic determinants on PIB. Four type-specific mAbs reacted with overlapping peptides in Varl between residues 192-198. Analysis of the effect of amino acid substitutions revealed that the mAb specificity is generated by differences in the effect of single amino acid changes on mAb binding, so that antigenic differences between strains are revealed by different patterns of reactivity within a panel of antibodies. The variable epitopes in Varl recognized by the type-specific mAbs lie in a hydrophilic region of the protein exposed on the gonococcal surface, and are accessible to complement-mediated bactericidal lysis. In contrast, the epitope recognized by mAb SM198 is highly conserved but is not exposed in the native protein and the antibody is non-bactericidal. However, the conserved epitope recognized by mAb SM24 is centred on residues 198-199, close to Varl, and is exposed for bactericidal killing.
Introduction
Protein I (PI) is the most abundant protein present on the surface of Neisseria gonorrhoeae and, unlike several other major surface antigens, does not undergo antigenic shift during infection (Zak et al., 1984) . PI appears to be essential for gonococcal viability, occurring in the outer membrane as a trimer which functions as an anionselective porin and allows uptake of essential nutrients (Young et af., 1983; Lynch et al., 1983) . In addition to its t Present address : School of Biological Sciences, University of porin activity, PI may play an important role in the pathogenesis of gonococcal infection, since in vitro studies have shown that, on contact, it may be transferred from the gonococcal outer membrane into the cell membrane of eukaryotic cells. Such a process may play a crucial role in gonococcal interaction with host cells in vivo (Blake, 1985) . Antibodies directed against PI have been shown to be opsonic for phagocytosis by polymorphonuclear leucocytes, to promote complement-mediated bactericidal killing and to inhi bit gonococcal damage to epithelial cells (Virji et af., 1986 (Virji et af., , 1987 . For these reasons PI is of considerable interest as a potential component of a gonococcal vaccine.
Although expression of PI is stable within a strain, differences occur between strains which are responsible for antigenic diversity. Thus, immunization with native PI results in the production of antibodies having limited reactivity with heterologous strains (Heckels et af., 1989) . Biochemical and immunological studies have revealed two major classes of PI (PIA and PIB); these can be further subdivided into a number of different serovars (Sandstrom et al., 1982; Knapp et al., 1984) . N . J . Butt 
and others
Antigenic analysis of PI has been aided by the use of monoclonal antibodies (mAbs). Differences in the pattern of reactivity of gonococcal strains with panels of mAbs have been utilized to define serovars of both PIAand PIB-expressing strains (Knapp et al., 1984; Sandstrom et al., 1985) . In our previous studies, a panel of mAbs was used to investigate the immunochemistry of PIB and the potential protective effect of antibodies directed against different PIB epitopes Virji et al., 1986) . Although the majority of mAbs obtained demonstrated restricted reactivity among the panel of strains tested, one antibody (SM24) was obtained which recognized 92 % of PIB-expressing strains . In in vitro studies mAb SM24 was opsonic, bactericidal and prevented cell damage, revealing the presence of a protective, but immunorecessive, conserved determinant on PIB. Such determinants represent attractive targets for vaccination.
Knowledge of the structure of the PIB molecule is therefore of considerable importance in attempting to identify both the conserved epitopes with vaccine potential and the variable epitopes responsible for serovar differences between strains. The nucleotide sequences of the genes (por) responsible for PIB expression in two strains have been determined (Gotschlich et al., 1987; Carbonetti et al., 1988) . Despite antigenic differences between the strains R10 and MS11, the inferred amino acid sequences show extensive homology, suggesting that limited structural variations may be responsible for generating antigenic diversity. In this paper we report the inferred amino acid sequence of PIB from strain P9, the immunobiology of which has been extensively studied (Heckels, 1977; Lambden & Heckels, 1979; Virji et al., 1986; Heckels et al., 1989 Heckels et al., , 1990 , and demonstrate that sequence variations occur between a number of other serovars in two discrete regions of the PIB molecule. In addition, we have used the sequence information to construct synthetic peptides and map the epitopes recognized by both the typespecific and cross-reacting, protective, anti-PIB mAbs.
Methods
Bacterial strains and growth conditions. Gonococci were grown on proteose peptone agar at 37°C in 5% (v/v) C02. Strain P9-17 (Pil+ PII+) has been described previously (Lambden & Heckels, 1979) ; strains SU50, SU75, SU85 and SU97 were local isolates (Zak et al., 1984) . Strain R10 was obtained from Professor E. C. Gotschlich, Rockefeller University, New York, USA, and strain MS11 was from Professor F. Sparling, University of North Carolina, USA. Serovar determination was done by Dr C. Ison, St Mary's Hospital Medical School, UK. mAbs. mAbs SM20, SM21, SM22 and SM24, which react with PIB from a number of gonococcal strains, were obtained following sequential immunization of mice with outer membranes from a variety of strains as described in detail previously . mAbs SM198 and SM203 were obtained subsequently using similar protocols after immunization of mice with outer membranes of strain P9 which had first been extracted with sodium cholate (Heckels, 1977) .
The reactivity of mAbs with gonococcal strains was determined by 'dot blotting' (Virji et al., 1987) ; antibody binding was detected with 251-protein A or goat anti-mouse IgG-alkaline phosphatase conjugate (Zymed) using AP colour development reagents (Bio-Rad) as substrates.
Sequence analysis of PIB. The complete nucleotide sequence of the por gene encoding expression of PIB in strain P9 has been determined (Butt et al., 1990) . This information was used to obtain the sequences of variable regions from other strains of gonococci using material generated by the polymerase chain reaction (PCR). Crude chromosomal DNA preparations were amplified using two primers spanning the region of interest : primer 17, GAATTCAAGCTT-570AACTACCAAAACAGCGGCTTCTTCG594; and primer 18, (un- derlined regions show additional bases carrying restriction sites used for subsequent cloning). Reactions were carried out in a Perkin-Elmer Cetus thermal cycler and subjected to 25 cycles of amplification. The cycle times were as follows: annealing, 2 min at 37 "C; primer extension, 3 min at 72 "C; denaturation, 1 min at 94 "C. On the last cycle the denaturation step was omitted and the extension step increased to 10 min. PCR-amplified material was digested with Hind111 and PstI and purified by agarose gel electrophoresis. The desired fragments were excised from the gel, purified by Geneclean (Bio 101) and cloned into MI 3mp18 or M13mp19. For each gonococcal variant templates were prepared from 10 recombinant phage, pooled and subjected to sequence analysis using dideoxy chain termination and deoxyadenosine 5'-~-[~~S]thiotriphosphate.
GTCGACCTGCAG-832GCGGTAGCGGCAACTTCGGT813
Computer analysis of the predicted protein secondary structure was done using the SEW, SEQNET node at Daresbury, UK, using the algorithms of Kyte & Doolittle (1982) and Hopp & Woods (1981) . Multiple sequence alignment was done using the CLUSTALL algorithm (Higgins & Sharp, 1988) .
Solid-phase peptide synthesis. This was done using a commercially available kit (Cambridge Research Biochemicals) in which peptides are synthesized onto polyethylene rods (Geysen et al., 1987) . Synthesis was done as described previously ) using pentafluorophenyl active esters of fluorenylmethoxycarbonyl-L-amino acids with t-butyl side-chain-protecting groups (Pfp-FMOC amino acids, Milligen), except in the case of methionine which had a trimethylsulphonyl side-chain-protecting group and serine and threonine in which the oxybenzotriazine active ester was used. After peptides of the desired length had been synthesized the terminal amino group was acetylated by reaction with acetic anhydride. Each synthesis was done in duplicate.
Detection of the immunological reactivities of the synthesized peptides on the rods was done by ELISA as described previously . The rods were incubated with mAbs in phosphatebuffered saline (PBS ; 0.15 M-SodiUm chloride, 0-15 M-sodium phosphate, pH 7.2) containing 1% BSA, 1% ovalbumin and 0.1% Tween 20. After washing and reaction with goat anti-mouse IgG conjugated to horseradish peroxidase (Zymed), colour was developed using 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulphonic acid) as substrate (Sigma). The solid-phase peptides were reused after bound antibody had been dissociated by sonication of the rods in 1% SDS, 0.1 % 2-mercaptoethanol in 0.1 M-phosphate buffer, pH 7-2, at 60 "C for 30 min. Immunological reactivity was always observed in duplicate peptides and in assays repeated on at least two occasions.
Results
mAb reactivity. The mAbs were tested by dot blotting against a panel of 25 gonococcal strains expressing PIA and 25 strains expressing PIB ( Table 1) . Greatest reactivity was seen with mAb SM198, which reacted with all PIB-expressing strains tested, and SM24, which reacted with 92% of PIB strains. As expected from previous studies the remaining antibodies reacted, in differing patterns, with over 30 % of PIB-expressing strains . None of the antibodies reacted with PIA-expressing gonococci or with meningococci. Five PIB-expressing strains of different serotype and reactivity pattern were chosen for further study and included one of the only two PIB-expressing strains which failed to react with mAb SM24. The reactivity of these strains, together with strains R10 and MSll for which the sequence of the PIB gene was available, is shown in Table 1 .
Reactivity of cross-reacting mAbs with peptides from strain RlO. The deduced amino acid sequence of PIB from strain R10 became available on the cloning of the PIB structural gene from that strain (Gotschlich et al., 1987) . To locate the epitopes recognized by the mAbs reacting with strain R10, a series of decapeptides spanning the entire molecule with adjacent peptides overlapping by five residues were synthesized and reacted with each of the mAbs. Antibody SM198 reacted with a single peptide corresponding to residues 106-1 15, whereas mAb SM24 reacted with two adjacent peptides corresponding to residues 19 1-200 and 196-205. No reaction was detected with the other mAbs used.
To define more precisely the epitope recognized by mAb SM198, a series of decapeptides corresponding to the region of interest, between residues 101 and 120, were synthesized with adjacent peptides differing by a single amino acid residue. Antibody SM198 reacted with six peptides all containing the common sequence lo7WESGK111 (Fig. la) , defining this as the minimum epitope recognized by the antibody.
To identify precisely the epitope recognized by mAb SM24, a series of hexapeptides were synthesized between residues 193 and 204, together with a series of smaller peptides centred on residue 198. Antibody SM24 reacted with five hexapeptides, all of which contained the sequence SI. Reactivity was approximately equal with the decapeptide 196TYSIPSLFVE205, the hexapeptide 96TYSIPS20 and the pentapeptide 96TYSIP200 defining this as the optimal minimum epitope (Fig. lb) . Nevertheless, significant reactivity was seen with all peptides containing SI, including the dipeptide itself ( Fig. 1 b) . The specificity of the reaction was confirmed by synthesizing the inverted peptide 200-1 96, which showed no reactivity with mAb SM24.
Reaction of type-spec@ mAbs with peptides from strain P9. To determine the epitopes recognized by the typespecific mAbs which did not react with peptides corresponding to strain R10, the complete amino acid sequence of strain P9 was required. The nucleotide sequence of the PIB gene from strain P9 was determined (Butt et al., 1990 ) and a comparison of the predicted amino acid sequences of PIB from strains P9, R10 and MSll is shown in Fig. 2 . The three sequences show considerable homology, with significant variations being 
. . largely confined to two regions centred on residues 196 and 237. A series of solid-phase decapeptides were synthesized corresponding to the P9 sequence in the variable regions between amino acids 182-208 and 227-243. Each of the antibodies tested reacted with one or more peptides in the region 182-208; none of the antibodies reacted with peptides corresponding to sequences from the region 227-243. Although the degree of reactivity varied considerably between the antibodies, considerable overlap was seen in the individual peptides recognized (Fig. 3a-d) . Thus, on the basis of the hexapeptides recognized, the minimum epitope recognized by both mAbs SM21 and SM203 was the hexapeptide 92YEHQVY 97, while that recognized by SM22 was the heptapeptide 1901EYEHQVY 1 9 7 . The reactivity seen with mAb SM20 was too weak to allow confident prediction of the epitope recognized, but results implicated the heptapeptide 19*YEHQVYS19*.
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Differences in amino acid sequences between strains and reaction of mAbs with variable peptides. The similarity in the epitopes recognized by the type-specific mAbs was somewhat surprising given their spectrum of reactivity with different strains. To investigate the effect of differences in amino acid sequences between strains on mAb binding, the sequence of the PIB gene between the positions coding for residues 166-250 was determined for each of the strains shown in Table 1 . Two oligonucleotide primers were synthesized, one corresponding to the coding sequence for amino acids 166-173 and the other complementary to the coding sequence for amino acids 247-253. These were used as primers in the PCR, to amplify the chromosomal DNA between these positions. The amplified DNA was cloned into M13 phage and sequenced. sequences determined in this way is shown in Fig. 4 . Significant differences between strains were found in the two regions previously noted. Sequence comparisons directly revealed the strain specificity of two mAbs. The putative epitope for mAb SM22 (IEYEHQVY) was present only in strains P9 and MS11 and only these strains reacted with the antibody. In addition, all the strains recognized by the broadly cross-reacting SM24 with the putative epitope TYSIPS contained at least the sequence YSIPS, while in the only two non-reacting strains tested this was replaced by the sequence YNIPS, reinforcing the necessary presence of the dipeptide SI. In contrast, the putative epitope (YEHQVY) recognized by mAbs SM21 and SM203 could not be confirmed by sequence comparison since it was not present in strain SU97 which reacted strongly with both antibodies.
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To examine the effect of any amino acid change on the reactivity of each mAb a series of peptides based on the decapeptide l 9 EYEHQVYSIP200 and the hexapeptide 196VYSIPS201 found in strain P9 were synthesized, in which individual amino acid residues were substituted, either singly or in combination, by each of the different residues found in the other strains. Reaction of these peptides with mAbs SM21, SM24 and SM203 revealed that some amino acid substitutions had little effect on mAb binding while others completely abolished reactivity (Fig. 5) peptide 191EYEHQVYSIP200 had no effect on the binding of mAbs SM21 or SM203, consistent with their reactivity with the sequence found in strain SU97. The two antibodies did show differences in reactivity when other substitutions were made. Antibody SM21 also reacted with peptides containing the substitutions 94S, 196Y or 196T but not 194D, while SM203 reacted with all substitutions at either position. The reactivity of SM21 was completely abolished by the substitution of D for 193E, consistent with its failure to react with all three strains containing this substitution. Reaction of SM203 was also abolished by the 193D substitution although it did show weak reactivity with one of these strains.
Antibody SM24 reacted equally well with all of the decapeptides, in accord with its reactivity with all six strains represented by the replacement peptides. SM24 also reacted with the hexapeptide 96VYSIPS201 and with the replacement peptide containing the substitution T for 196V. Reactivity of SM24 was however completely abolished by the substitution N for lg8S, again consistent with its failure to react with the two strains containing this substitution.
Discussion
Comparison of the deduced primary amino acid sequence of PIB from strain P9 with those previously reported for strains R10 and MSll confirms the considerable homology between the antigenically distinct proteins, with less than 5 % sequence difference between the strains. Such homology suggests a conserved three-dimensional structure of the proteins in accord with a highly conserved functional role as a porin (Young et al., 1983; Lynch et al., 1983) and also perhaps in interactions with host cells (Blake, 1985) . The similarity between the deduced amino acid sequences suggests that antigenic differences between strains must largely result from sequence variations in localized regions. The sequence alignment of the three proteins indicates two such regions centred on residues 196 (Varl) and 237 (Var2), and the variability of these regions is confirmed by the partial sequences of a further five strains.
The localization of linear epitopes recognized by mAbs has been greatly facilitated by the development of techniques for the concurrent synthesis of large numbers of peptides for testing by ELISA (Geysen et al., 1987; . Using this technique it was revealed that five of the six mAbs tested reacted with peptides corresponding to the residues between positions 190 and 201 with the four type-specific mAbs reacting with overlapping peptides in the region 192-198 and the broadly cross-reacting mAb SM24 recognizing the sequence 196TYSIP200.
The close similarity and indeed apparent identity of the epitopes recognized by mAbs on strain P9 (Table 2) was initially surprising given the differing patterns of strain reactivity seen with the antibodies. However, analysis of the effect of amino acid substitutions reveals that additional mAb specificity is generated by differences in the influence of single amino acid changes on mAb binding. Indeed it seems likely that given the limited variation between the proteins, any scheme for serological differentiation of PI must rely on similar influences on mAb binding, so that antigenic differences between strains are recognized not simply by their reactivity with individual mAbs but rather by different patterns of reactivity with a panel of antibodies. This is precisely the situation with two schemes for the definition of serovars of PIB (Knapp et al., 1984;  
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Sandstrom et al. , 1985) . Although in the current study each of the type-specific antibodies reacted with sequences in Varl, it would appear likely that sequence differences in Var2 could also generate epitopes with potential for serological differentiation. Indeed, this appears to be the case, since strains P9 and MS11, which belong to different serovars, have identical sequences in Varl but differ significantly in Var2. It therefore appears likely that the antigenic diversity of PIB is largely generated by sequence variation in only two discrete regions of the molecule. Despite antigenic differences between the strains, comparison of the sequences shows significant conservation of sequences in the variable regions of strains from different geographical locations. Thus strain MS11, isolated in the USA, shows homology with the British isolates strain P9 in Varl but not in Var2 and, in contrast, with strain SU97 in Var2 but not Varl. Such mixing and matching between the two variable regions suggests that one mechanism by which genetic diversity may have arisen involved recombination events between the por genes of different strains. In this context it is interesting to compare this situation with that of the closely related meningococcus. Meningococci express two rather than one porin proteins (Barlow et al., 1989; West & Clarke, 1989) , the class 1 and class 2/3 proteins, which are responsible for serotype and subtype specificity, respectively (Frasch et al., 1985) . PIB shows significant sequence homology with both proteins (Barlow et al., 1989; Murakami et al., 1989) suggesting similar organization within the outer membrane. Comparative sequence analysis and epitope mapping on the class 1 protein have also revealed two discrete variable regions, and that mixing and matching of these sequences in these regions generates two independent sero-subtype specificities in each strain (McGuiness et al., 1990) . Interestingly these meningococcal variable domains occur at quite different regions of the molecule to the variable regions on PIB.
Immunization with outer membranes or detergent micelles containing PI in its native conformation (Kersten et al., 1988; Wetzler et al., 1988) produces antibodies which are type-specific, demonstrating that the variable determinants are immunodominant. Secondary structural analysis of PIB from strain P9 shows alternating domains of hydrophilic and hydrophobic residues similar to those reported for PIA (Carbonetti & Sparling, 1987) and typical of other outer transmembrane proteins (Vogel & Jagnig, 1986) . Thus, although several hydrophilic domains of the protein may be exposed on the bacterial surface it appears that those containing variable determinants are particularly accessible to the immune system and hence are particularly immunogenic. The surface exposure of Varl is also consistent with the ability of all the antibodies recognizing sequences within it to react with the native protein and, in addition, to cause complement-mediated bactericidal killing. In contrast, the epitope recognized by mAb SM198 lies in a region of low hydrophilicity, the antibody reacts only weakly with intact cells and is not bactericidal, suggesting that it is not well exposed on the surface of the gonococcus.
Antibodies to PI may be particularly important in preventing the complications associated with gonococcal infection. Bactericidal antibodies directed against PI produced in response to gonococcal salpingitis appear to protect against reinfection by strains of the same serovar (Buchanan et al., 1980) . Clearly any potential vaccine should produce immunity to the widest possible range of strains. The location of the epitope, 196TYSIP200 recognized by mAb SM24 is therefore of particular interest since this antibody reacts with, and is bactericidal for, 92% of PIB-expressing strains tested . Comparison of the sequences reveals the reason for the failure of this broadly cross-reacting antibody to react with two of the panel of strains, since these both contain in Varl the sequence YNIPS, which lacks the essential dipeptide at the centre of the epitope. In a previous study the SM24 epitope was shown to lie between residues 193-204 and synthetic peptide corresponding to this region 193-204 from strain R10 was used to immunize rabbits (Heckels et al., 1990) . The sera obtained reacted with native PI from the homologous strains and were bactericidal for it, but showed only limited reactivity with strain P9. The reason for the limited cross-reactivity of the antisera raised against the peptide containing the conserved SM24 epitope is now revealed since the sera obtained showed specificity for the N terminus of the peptide, containing the sequence differences found in Varl, rather than the C terminus N . J . Butt and others which contains the conserved epitope. Clearly, future studies with synthetic peptides will greatly benefit from the insight into the structure and immunochemistry of PIB provided by the current studies. This work was supported by an MRC Project Grant. N.B. was in receipt of MRC Research Studentship.
